Can costs be measured and predicted by modeling within a cooperative clinical trials group? Economic methodologic pilot studies of the radiation therapy oncology group (RTOG) studies 90-03 and 91-04OWEN, Jean B; GRIGSBY, Perry W; CALDWELL, Thomas M et al.International journal of radiation oncology, biology, physics. 2001, Vol 49, Num 3, pp 633-639, issn 0360-3016Conference Paper

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckBONNER, James A; HARARI, Paul M; OVE, Roger et al.The New England journal of medicine. 2006, Vol 354, Num 6, pp 567-578, issn 0028-4793, 12 p.Article

Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate CancerJONES, Christopher U; HUNT, Daniel; SANDLER, Howard M et al.The New England journal of medicine. 2011, Vol 365, Num 2, pp 107-118, issn 0028-4793, 12 p.Article

RTOG 97-06: Initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapyHAGAN, Michael P; WINTER, Kathryn A; KAUFMAN, Donald S et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 3, pp 665-672, issn 0360-3016, 8 p.Article

Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation Therapy Oncology Group phase II trial 99-14KIAN ANG, K; HARRIS, Jonathan; GARDEN, Adam S et al.Journal of clinical oncology. 2005, Vol 23, Num 13, pp 3008-3015, issn 0732-183X, 8 p.Article

p105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: A clinical/laboratory correlative analysis of RTOG-9003HAMMOND, E; BERKEY, Brian A; FU, Karen K et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 3, pp 683-692, issn 0360-3016, 10 p.Article